Pharmaids Pharmaceuticals Ltd — Updates, 30-07-2025: Company Update

Pharmaids Pharmaceuticals has announced the independent directors' assessment of the ongoing open offer. An acquirer, along with a PAC, is seeking to purchase up to 9,169,632 equity shares at ₹62.15 per share, totaling approximately ₹56.99 Cr. The independent directors' views on this offer have been published in newspapers, providing crucial information to public shareholders. This assessment helps shareholders evaluate the offer and make an informed decision regarding tendering their shares.